<DOC>
	<DOC>NCT01456546</DOC>
	<brief_summary>The aim of this study is to investigate if the genetic variant CYP2C19*17 affects the pharmacokinetics of proguanil and clopidogrel.</brief_summary>
	<brief_title>Impact of CYP2C19*17 on the Pharmacokinetics of Proguanil and Clopidogrel</brief_title>
	<detailed_description />
	<mesh_term>Clopidogrel</mesh_term>
	<mesh_term>Ticlopidine</mesh_term>
	<mesh_term>Proguanil</mesh_term>
	<criteria>Healthy volunteers Written consent Age 1865 CYP2C19*1 and or CYP2C19*17 genotype. Daily medication Alcohol abuse Pregnancy Breastfeeding</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>July 2013</verification_date>
	<keyword>CYP2C19*17</keyword>
	<keyword>Pharmacokinetics</keyword>
	<keyword>Pharmacodynamics</keyword>
</DOC>